Genomic profiling of renal cell carcinoma in patients with end-stage renal disease

Cancer Science

Volumn 103, Issue 3, 2012, Pages 569-576

  Inoue, Toru ^a   Matsuura, Keiko ^a   Yoshimoto, Taichiro ^b   Nguyen, Lam Tung ^a   Tsukamoto, Yoshiyuki ^a   Nakada, Chisato ^a   Hijiya, Naoki ^a   Narimatsu, Takahiro ^a   Nomura, Takeo ^a   Sato, Fuminori ^a   Nagashima, Yoji ^c   Kashima, Kenji ^d   Hatakeyama, Shingo ^e   Ohyama, Chikara ^e   Numakura, Kazuyuki ^f   Habuchi, Tomonori ^f   Nakagawa, Masayuki ^g   Seto, Masao ^h   Mimata, Hiromitsu ^a   Moriyama, Masatsugu ^a  

^a OITA UNIVERSITY   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d OITA UNIVERSITY HOSPITAL   (Japan)

^e HIROSAKI UNIVERSITY   (Japan)

^f AKITA UNIVERSITY   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 7P; CHROMOSOME 7Q; CLEAR CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; CHRONIC KIDNEY FAILURE; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENETICS; KIDNEY TUMOR; LASER CAPTURE MICRODISSECTION; PATHOLOGY;

CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION PROFILING; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; LASER CAPTURE MICRODISSECTION;

EID: 84859721097     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02176.x     Document Type: Article

References (32)

1. Ishikawa I. Uremic acquired renal cystic disease. Natural history and complications. Nephron 1991; 58: 257-67.
2. Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997; 158: 42-4.
3. Terasawa Y, Suzuki Y, Morita M, Kato M, Suzuki K, Sekino H. Ultrasonic diagnosis of renal cell carcinoma in hemodialysis patients. J Urol 1994; 152: 846-51.
4. Nouh MA, Kuroda N, Yamashita M et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int 2010; 105: 620-7.
5. Ianhez LE, Lucon M, Nahas WC et al. Renal cell carcinoma in renal transplant patients. Urology 2007; 69: 462-4.
6. Moudouni SM, Lakmichi A, Tligui M et al. Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int 2006; 98: 298-302.
7. Denton MD, Magee CC, Ovuworie C et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 2002; 61: 2201-9.
8. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993; 22: 135-9.
9. Tickoo SK, dePeralta-Venturina MN, Harik LR et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141-53.
10. Gobbo S, Eble JN, Grignon DJ et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008; 32: 1239-45.
11. Gunawan B, Huber W, Holtrup M et al. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res 2001; 61: 7731-8.
12. Klatte T, Rao PN, de Martino M et al. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol 2009; 27: 746-53.
13. Toma MI, Grosser M, Herr A et al. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density Affymetrix 10K single nucleotide polymorphism mapping array. Neoplasia 2008; 10: 634-42.
14. Yoshimoto T, Matsuura K, Karnan S et al. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J Pathol 2007; 213: 392-401.
15. Gunawan B, von Heydebreck A, Fritsch T et al. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res 2003; 63: 6200-5.
16. Kim HJ, Shen SS, Ayala AG et al. Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality. Am J Surg Pathol 2009; 33: 1276-86.
17. Klatte T, Pantuck AJ, Said JW et al. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res 2009; 15: 1162-9.
18. Cossu-Rocca P, Eble JN, Zhang S, Martignoni G, Brunelli M, Cheng L. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 2006; 19: 780-7.
19. Eble JN. Tumors of the kidney. In: Eble JN, Sauter G, Epstein JI et al. eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004, 9-87.
20. Amin MB, MacLennan GT, Gupta R et al. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 2009; 33: 384-92.
21. Uchida M, Tsukamoto Y, Uchida T et al. Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization. J Pathol 2010; 221: 96-105.
22. Choyke PL. Acquired cystic kidney disease. Eur Radiol 2000; 10: 1716-21.
23. Ishikawa I. Acquired cystic disease of the kidney and renal cell carcinoma. Tokyo: Springer, 2007; 57-8.
24. Cheuk W, Lo ES, Chan AK, Chan JK. Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 2002; 33: 761-5.
25. Chudek J, Herbers J, Wilhelm M et al. The genetics of renal tumors in endstage renal failure differs from those occurring in the general population. J Am Soc Nephrol 1998; 9: 1045-51.
26. Gronwald J, Baur AS, Holtgreve-Grez H et al. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization. J Pathol 1999; 187: 308-12.
27. Inoue H, Nonomura N, Kojima Y et al. Somatic mutations of the von Hippel- Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrol Dial Transplant 2007; 22: 2052-5.
28. Yoshida M, Yao M, Ishikawa I et al. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney. Genes Chromosom Cancer 2002; 35: 359-64.
29. Kuroda N, Shiotsu T, Hes O, Michal M, Shuin T, Lee GH. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol 2010; 43: 231-4.
30. Sule N, Yakupoglu U, Shen SS et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 2005; 29: 443-51.
31. Ishikawa I. Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002. Nephron Clin Pract 2004; 97: c11-6.
32. Hori Y, Oda Y, Kiyoshima K et al. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. J Pathol 2007; 212: 218-26.